GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions

Journal of Neurotrauma

Volumn 31, Issue 22, 2014, Pages 1815-1822

  Papa, Linda ^a   Silvestri, Salvatore ^a   Brophy, Gretchen M ^b   Giordano, Philip ^a   Falk, Jay L ^a   Braga, Carolina F ^a   Tan, Ciara N ^a   Ameli, Neema J ^a   Demery, Jason A ^c   Dixit, Neha K ^c   Mendes, Matthew E ^d   Hayes, Ronald L ^e   Wang, Kevin K W ^f   Robertson, Claudia S ^g  

^a ORLANDO REGIONAL MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Geriatric Research Education and Clinical Center   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA   (United States)

^e BANYAN BIOMARKERS INC   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Computed tomography (CT); Fractures; Glial fibrillary acidic protein (GFAP); Mild traumatic brain injury concussion; S100

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B; BIOLOGICAL MARKER; S100B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LIMB FRACTURE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY; TRUNK; ADOLESCENT; AREA UNDER THE CURVE; BLOOD; BRAIN INJURIES; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTURE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN INJURIES; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTURES, BONE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; ROC CURVE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84912000278     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3245     Document Type: Article

References (32)

1. Kochanek, P.M., Berger, R.P., Bayr, H., Wagner, A.K., Jenkins, L.W., and Clark, R.S. (2008) Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care 14, 135-141.
2. Papa, L. (2012) Exploring the role of biomarkers for the diagnosis and management of traumatic brain injury patients, in: Poteomics - Human Diseases and Protein Functions. Man, T.K. and Flores, R.J. (eds). In Tech Open Access Publisher.
3. Papa, L., Ramia, M.M., Kelly, J.M., Burks, S.S., Pawlowicz, A., and Berger, R.P. (2013) Systematic review of clinical research on biomarkers for pediatric traumatic brain injury. J Neurotrauma 30, 324-38.
4. Xiong, H., Liang, W.L., and Wu, X.R. (2000) [Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation]. Sheng Li Ke Xue Jin Zhan 31, 217-221.
5. Ingebrigtsen, T., Romner, B., Marup-Jensen, S., Dons, M., Lundqvist, C., Bellner, J., Alling, C., and Borgesen, S.E. (2000) The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj. 14, 1047-1055.
6. Muller, K., Townend, W., Biasca, N., Unden, J., Waterloo, K., Romner, B., and Ingebrigtsen, T. (2007) S100B serum level predicts computed tomography findings after minor head injury. J. Trauma 62, 1452-1456.
7. Biberthaler, P., Linsenmeier, U., Pfeifer, K.J., Kroetz, M., Mussack, T., Kanz, K.G., Hoecherl, E.F., Jonas, F., Marzi, I., Leucht, P., Jochum, M., and Mutschler, W. (2006) Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study. Shock 25, 446-453.
8. Phillips, J.P., Jones, H.M., Hitchcock, R., Adama, N., and Thompson, R.J. (1980) Radioimmunoassay of serum creatine kinase BB as index of brain damage after head injury. BMJ 281, 777-779.
9. Rothoerl, R.D., Woertgen, C., Holzschuh, M., Metz, C., and Brawanski, A. (1998) S-100 serum levels after minor and major head injury. J. Trauma 45, 765-767.
10. Piazza, O., Storti, M.P., Cotena. S., Stoppa, F., Perrotta, D., Esposito, G., Pirozzi, N., and Tufano, R. (2007) S100B is not a reliable prognostic index in paediatric TBI. Pediatr. Neurosurg. 43, 258-264.
11. Bechtel K, Frasure S, Marshall C, Dziura J, and Simpson, C. (2009) Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Pediatrics 124, e697-e704.
12. Rothoerl, R.D. and Woertgen, C. (2001) High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1490-1491.
13. Romner, B., Ingebrigtsen, T. (2001) High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1490.
14. Anderson, R.E., Hansson, L.O., Nilsson, O., Dijlai-Merzoug, R., and Settergen, G. (2001) High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1272-1273.
15. Pelinka, L.E., Kroepfl, A., Schmidhammer, R., Krenn, M., Buchinger, W., Redl, H., and Raabe, A. (2004) Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma 57, 1006-1012.
16. Unden, J., Bellner, J., Eneroth, M., Alling, C., Ingebrigtsen, T., and Romner, B. (2005) Raised serum S100B levels after acute bone fractures without cerebral injury. J. Trauma 58, 59-61.
17. Zimmer, D.B., Cornwall, E.H., Landar, A., and Song, W. (1995) The S100 protein family: history, function, and expression. Brain Res. Bull. 37, 417-429.
18. Olsson, B., Zetterberg, H., Hampel, H., and Blennow, K. (2011) Biomarker-based dissection of neurodegenerative diseases. Prog. Neurobiol. 95, 520-534.
19. Jagoda, A.S., Bazarian, J.J., Bruns, J.J., Jr., Cantrill, S.V., Gean, A.D., Howard, P.K., Ghajar, J., Riggio, S., Wright, D.W., Wears, R.L., Bakshy, A., Burgess, P., Wald, M.M., and Whitson, R.R. (2008) Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann. Emerg. Med. 52, 714-748.
20. Eng, L.F., Vanderhaeghen, J.J., Bignami, A., and Gerstl., B. (1971) An acidic protein isolated from fibrous astrocytes. Brain Res. 28, 351-354.
21. Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., and Hagenstrom, H. (1999) Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin. Chem. 45, 138-141.
22. Pelinka, L.E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., and Redl, H. (2004) GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J. Neurotrauma 21, 1553-1561.
23. van Geel, W.J., de Reus, H.P., Nijzing, H., Verbeek, M.M., Vos, P.E., and Lamers, K.J. (2002) Measurement of glial fibrillary acidic protein in blood: an analytical method. Clin. Chim. Acta 326, 151-154.
24. Nylen, K., Ost, M., Csajbok, L.Z., Nilsson, I., Blennow, K., Nellgard, B., and Rosengren, L. (2006) Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J. Neurol. Sci. 240, 85-91.
25. Mondello, S., Papa, L., Buki, A., Bullock, R., Czeiter, E., Tortella, F., Wang, K.K, and Hayes, R.L. (2011) Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit. Care 15:R156.
26. Metting, Z., Wilczak, N., Rodiger, L.A, Schaaf, J.M., and van der Naalt, J. (2012) GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 78, 1428-1433.
27. Papa, L., Lewis, L.M., Falk, J.L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G.M., Demery, J.A., Dixit, N.K., Ferguson, I., Liu, M.C., Mo, J., Akinyi, L., Schmid, K., Mondello, S., Robertson, C.S., Tortella, F.C., Hayes, R.L., and Wang, K.K. (2012) Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann. Emerg. Med. 59, 471-483.
28. Bohmer, A.E., Oses, J.P., Schmidt, A.P., Peron, C.S., Krebs, C.L., Oppitz, P.P., D'Avila, T.T., Souza, D.O., Portela, L.V., and Stefani, M.A. (2011) Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68, 1624-1630.
29. Vos, P.E., Jacobs, B., Andriessen, T.M., Lamers, K.J., Borm, G.F., Beems, T., Edwards, M., Rosmalen, C.F., and Vissers, J.L. (2010) GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 75, 1786-1793.
30. Zurek, J. and Fedora, M. (2012) The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir. (Wien) 154, 93-103.
31. Honda, M., Tsuruta, R., Kaneko, T., Kasaoka, S., Yagi, T., Todani, M., Fujita, M., Izumi, T., and Maekawa, T. (2010) Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J. Trauma 69, 104-109.
32. Vajtr, D., Benada, O., Linzer, P., Samal, F., Springer, D., Strejc, P., Beran, M., Prusa, R., and Zima, T. (2013) Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek 57, 7-12.